STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma.
Saved in:
| Title: | STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma. |
|---|---|
| Authors: | Ploeger C; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Schreck J; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Huth T; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Fraas A; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Albrecht T; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Charbel A; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Ji J; The MOE Key Laboratory of Biosystems Homeostasis & Protection, Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou 310058, China., Singer S; Institute of Pathology and Neuropathology, Eberhard-Karls University, 72076 Tuebingen, Germany., Breuhahn K; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Pusch S; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Köhler BC; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany., Springfeld C; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany., Schirmacher P; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Mehrabi A; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany., Goeppert B; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany., Roessler S; Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Liver Cancer Center Heidelberg (LCCH), 69120 Heidelberg, Germany. |
| Source: | Cancers [Cancers (Basel)] 2022 Feb 23; Vol. 14 (5). Date of Electronic Publication: 2022 Feb 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers14051154 |
